Retrospective study develops a nomogram predicting graft failure in pediatric liver transplant recipients, highlighting its clinical utility.
OBJECTIVE: • • •. BACKGROUND: To develop and validate a preoperative APRI-ALBI-based nomogram for predicting graft failure (GF) after pediatric liver transplantation. METHODS: A single-center, retrospective cohort of 289 children who underwent primary liver transplantation for end-stage liver disease between April 2017 and September 2024 was enrolled. Forty-two recipient, donor and intra-operative variables were collected. Candidate predictors were first screened by univariate Logistic/Cox analysis, further reduced by LASSO regression with 10-fold cross-validation, and finally entered into multivariable models. A nomogram integrating APRI-ALBI and other independent risk factors was constructed. Model discrimination, calibration and clinical utility were assessed with ROC analysis, calibration plots, Hosmer-Lemeshow test, decision-curve analysis (DCA) and restricted cubic splines (RCS). Kaplan-Meier curves and time-dependent ROC were used to validate 1- and 3-year GF prediction. RESULTS: < 0.01). Time-dependent ROC curves demonstrated excellent predictive accuracy at 30 days and 1 year (AUC 0.899-0.977). CONCLUSION: APRI-ALBI is an independent risk factor for GF in pediatric liver transplantation. The APRI-ALBI-based nomogram offers robust discrimination, calibration and clinical utility for individual risk stratification.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: